SCHEMBL28969031

SCHEMBL28969031

O=C(N[C@@H](Cc1ncc(-c2ccc(Br)cc2)o1)C(=O)O)OCc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPPA P01160 2/20 0.47
MME P08473 2/20 0.47
ITGA4 P13612 1/20 0.46
ITGB7 P26010 1/20 0.46
ITGB3 P05106 5/20 0.46
ITGA2B P08514 5/20 0.46
TACR1 P25103 1/20 0.45
HDAC3 O15379 2/20 0.45
HDAC4 P56524 2/20 0.45
HDAC1 Q13547 2/20 0.45
HDAC7 Q8WUI4 2/20 0.45
HDAC2 Q92769 2/20 0.45
HDAC10 Q969S8 2/20 0.45
HDAC11 Q96DB2 2/20 0.45
HDAC8 Q9BY41 2/20 0.45
HDAC6 Q9UBN7 2/20 0.45
HDAC9 Q9UKV0 2/20 0.45
HDAC5 Q9UQL6 2/20 0.45
CTSL P07711 2/20 0.45
CTSB P07858 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28968928 1.00 NPPA (0.47) NPPAMMEITGA4ITGB7ITGB3
SCHEMBL6254719 0.94 NPPA (0.52) NPPAMMEITGA4ITGB7ITGB3
SCHEMBL30306923 0.91 ATM (0.43) NPPAMMETACR1HDAC3HDAC4
SCHEMBL30306910 0.84 SIRT2 (0.51)
SCHEMBL6508639 0.84 ATM (0.47) NPPAMMETACR1CTSLCTSB
SCHEMBL6807219 0.82 SYK (0.47) NPPAMMEITGB3ITGA2BTACR1
SCHEMBL6807187 0.81 PPARA (0.48) NPPAMMETACR1HDAC3HDAC4
SCHEMBL6806843 0.81 MGLL (0.43) NPPAMMETACR1CTSLCTSB
SCHEMBL2975870 0.79 ITGB3 (0.63) ITGB3ITGA2BTACR1CTSLCTSB
SCHEMBL502349 0.79 ITGB3 (0.63) ITGB3ITGA2BTACR1CTSLCTSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4171547-A1 TLR2 MODULATOR COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF Axial Therapeutics, Inc. (US) 2023-05-03 EP disclosed
CN-115666553-A TLR2 modulator compounds, and pharmaceutical compositions and uses thereof 轴向治疗公司 2023-01-31 CN disclosed